Nebenwirkungen · Votrient
Votrient 200 mg film-coated tablets Votrient 400 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 18–19
HOS-122606 · Präparat HOS-095539
18 Very common Hair colour change 93 (24%) 0 0 Skin hypopigmentation 80 (21%) 0 0 Exfoliative rash 52 (14%) 2 (<1%) 0 Common Alopecia 30 (8%) 0 0 Skin disorderc 26 (7%) 4 (1%) 0 Dry skin 21 (5%) 0 0 Hyperhydrosis 18 (5%) 0 0 Nail disorder 13 (3%) 0 0 Skin and Pruritus 11 (3%) 0 0 subcutaneous disorders Erythema 4 (1%) 0 0 Uncommon Skin ulcer 3 (<1%) 1 (<1%) 0 Rash 1 (<1%) 0 0 Rash papular 1 (<1%) 0 0 Photosensitivity 1 (<1%) 0 0 reaction Palmar-plantar 2 (<1%) 0 0 erythrodysaesthesia syndrome Common Musculoskeletal pain 35 (9%) 2 (<1%) 0 Musculoskeletal Myalgia 28 (7%) 2 (<1%) 0 and connective Muscle spasms 8 (2%) 0 0 tissue disorders Uncommon Arthralgia 2 (<1%) 0 0 Renal and Uncommon Proteinuria 2 (<1%) 0 0 urinary disorders Reproductive Uncommon Vaginal haemorrhage 3 (<1%) 0 0 system and breast Menorrhagia 1 (<1%) 0 0 disorder Very common Fatigue 178 (47%) 34 (9%) 1 (<1%) General disorders Common Oedemab 18 (5%) 1 (<1%) 0 and Chest pain 12 (3%) 4 (1%) 0 administration Chills 10 (3%) 0 0 site conditions Uncommon Mucosal inflammatione 1 (<1%) 0 0 Asthenia 1 (<1% 0 0
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-28T11:24:00Z · SHA-256 38e00132fe316301c56a9c9a4f9247483c54b55dd743bedaab120a272380aaff · Passage c7d318f65dd5b366eb3c688d82820fd89f2b40f46bda22a039e04e103026f206 · Zeichen 28127–30669 im Abschnitt